157 related articles for article (PubMed ID: 16510484)
1. The acute and long-term neurotoxic effects of MDMA on marble burying behaviour in mice.
Saadat KS; Elliott JM; Colado MI; Green AR
J Psychopharmacol; 2006 Mar; 20(2):264-71. PubMed ID: 16510484
[TBL] [Abstract][Full Text] [Related]
2. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
[TBL] [Abstract][Full Text] [Related]
3. Effect of acute brain tyrosine depletion on MDMA-induced changes in brain 5-HT.
Rodsiri R; Green AR; Marsden CA; Fone KC
J Psychopharmacol; 2010 Feb; 24(2):267-74. PubMed ID: 19965941
[TBL] [Abstract][Full Text] [Related]
4. Ecstasy: are animal data consistent between species and can they translate to humans?
Easton N; Marsden CA
J Psychopharmacol; 2006 Mar; 20(2):194-210. PubMed ID: 16510478
[TBL] [Abstract][Full Text] [Related]
5. A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on the subsequent long-term behaviour of rats in the plus maze and open field.
Mechan AO; Moran PM; Elliott M; Young AJ; Joseph MH; Green R
Psychopharmacology (Berl); 2002 Jan; 159(2):167-75. PubMed ID: 11862345
[TBL] [Abstract][Full Text] [Related]
6. Atypical development of behavioural sensitization to 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') in adolescent rats and its expression in adulthood: role of the MDMA chirality.
von Ameln N; von Ameln-Mayerhofer A
Addict Biol; 2010 Jan; 15(1):35-44. PubMed ID: 20002021
[TBL] [Abstract][Full Text] [Related]
7. Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition in squirrel monkeys before and after neurotoxic MDMA administration.
Winsauer PJ; McCann UD; Yuan J; Delatte MS; Stevenson MW; Ricaurte GA; Moerschbaecher JM
Psychopharmacology (Berl); 2002 Feb; 159(4):388-96. PubMed ID: 11823891
[TBL] [Abstract][Full Text] [Related]
8. Acute behavioural and neurotoxic effects of MDMA plus cocaine in adolescent mice.
Daza-Losada M; Rodríguez-Arias M; Maldonado C; Aguilar MA; Guerri C; Miñarro J
Neurotoxicol Teratol; 2009; 31(1):49-59. PubMed ID: 18718862
[TBL] [Abstract][Full Text] [Related]
9. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
Green AR; Mechan AO; Elliott JM; O'Shea E; Colado MI
Pharmacol Rev; 2003 Sep; 55(3):463-508. PubMed ID: 12869661
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT.
Darvesh AS; Gudelsky GA
Brain Res; 2005 Sep; 1056(2):168-75. PubMed ID: 16098955
[TBL] [Abstract][Full Text] [Related]
11. Behavioural and neurotoxic long-lasting effects of MDMA plus cocaine in adolescent mice.
Daza-Losada M; Rodríguez-Arias M; Maldonado C; Aguilar MA; Miñarro J
Eur J Pharmacol; 2008 Aug; 590(1-3):204-11. PubMed ID: 18585379
[TBL] [Abstract][Full Text] [Related]
12. Long-lasting behavioral sensitization to psychostimulants following p-chloroamphetamine-induced neurotoxicity in mice.
Itzhak Y; Achat-Mendes CN; Ali SF; Anderson KL
Neuropharmacology; 2004 Jan; 46(1):74-84. PubMed ID: 14654099
[TBL] [Abstract][Full Text] [Related]
13. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
Clemens KJ; McGregor IS; Hunt GE; Cornish JL
Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831
[TBL] [Abstract][Full Text] [Related]
14. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine.
Colado MI; O'Shea E; Granados R; Murray TK; Green AR
Br J Pharmacol; 1997 Jul; 121(5):889-900. PubMed ID: 9222545
[TBL] [Abstract][Full Text] [Related]
15. Serotonin transporter expression is not sufficient to confer cytotoxicity to 3,4-methylenedioxymethamphetamine (MDMA) in vitro.
Hayat S; Williams RJ; Rattray M
J Psychopharmacol; 2006 Mar; 20(2):257-63. PubMed ID: 16510483
[TBL] [Abstract][Full Text] [Related]
16. Early loss of dopaminergic terminals in striosomes after MDMA administration to mice.
Granado N; Escobedo I; O'Shea E; Colado I; Moratalla R
Synapse; 2008 Jan; 62(1):80-4. PubMed ID: 17960765
[TBL] [Abstract][Full Text] [Related]
17. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
Camarasa J; Pubill D; Escubedo E
Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
[TBL] [Abstract][Full Text] [Related]
18. Effect of a serotonin depleting regimen of 3,4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex.
Nair SG; Gudelsky GA
Brain Res Bull; 2006 Apr; 69(4):382-7. PubMed ID: 16624669
[TBL] [Abstract][Full Text] [Related]
19. Effects of antipsychotics and reference monoaminergic ligands on marble burying behavior in mice.
Bruins Slot LA; Bardin L; Auclair AL; Depoortere R; Newman-Tancredi A
Behav Pharmacol; 2008 Mar; 19(2):145-52. PubMed ID: 18332679
[TBL] [Abstract][Full Text] [Related]
20. Mice with decreased cerebral dopamine function following a neurotoxic dose of MDMA (3,4-methylenedioxymethamphetamine, "Ecstasy") exhibit increased ethanol consumption and preference.
Izco M; Marchant I; Escobedo I; Peraile I; Delgado M; Higuera-Matas A; Olias O; Ambrosio E; O'Shea E; Colado MI
J Pharmacol Exp Ther; 2007 Sep; 322(3):1003-12. PubMed ID: 17526809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
